Bain Healthcare Insights

  • Opportunities in integrated care for pharma and medtech

    September 25, 2013 | Healthcare | Bain Brief

    Everyone may be talking about integrated care, but what does it really mean for the business models of pharma and medtech? Several key questions merit consideration. Are there unmet needs in care integration for the disease states where you play? Do you have distinctive assets and competencies to

  • Asia: Healthcare's biggest M&A opportunity and challenge

    September 19, 2013 | Healthcare | Forbes.com

    The sheer scale of Asia’s developing economies is turning them into some of the hottest markets for pharmaceuticals and medical devices.

  • Building a fully integrated biotech company: What it takes

    September 09, 2013 | Healthcare | IN VIVO

    The transition from R&D to a fully integrated stage is a make-or-break scenario for any biotech company. High-quality marketed products alone don't guarantee a successful transformation--it also requires strategic focus and an organization capable of delivering on that ambition.

  • A new approach to M&A helps healthcare companies grow in Asia

    June 25, 2013 | Healthcare | Bain Brief

    Winning healthcare companies are discovering a unique approach to inorganic growth that sets them up for success in Asia over the long haul. They use a portfolio management strategy that builds a combination of sustainable assets across countries, sectors and risk profiles, relying on an M&A

  • The pharmaceutical industry and the challenge with generic - Bain Milan

    June 24, 2013 | Strategy, Healthcare | Quotidiano Sanità

    The main difference in the pharmaceutical industry today compared to the recent past is not in the "recipe" of dealing with change, but the inevitability of putting it in place. It’s time for more radical evaluations and decisions.

  • Webinar: A new pharma launch paradigm

    June 13, 2013 | Healthcare | Bain video

    In this webinar, Michael Kunst and Rafael Natanek, co-authors of A new pharma launch paradigm: From one size fits all to a tailored product approach, discuss how pharmaceutical companies can launch successful products in a market with higher hurdles to access and increased competition.

  • A new pharma launch paradigm: From one size fits all to a tailored product approach

    June 05, 2013 | Healthcare | Bain Brief

    Market access restrictions and fragmented pipelines are creating challenges for pharmaceutical companies trying to introduce new products. Successful pharmaceutical companies are tailoring their launches to one of four product archetypes and retooling their organizations into Launch Factories

  • Five obstacles to a healthier world

    May 23, 2013 | Healthcare | Forbes.com

    To improve public health, business and government leaders will likely grapple with several worldwide trends, many of them byproducts of technological advances and economic development.

  • Healthy living: Economic necessity and business opportunity

    May 06, 2013 | Bain industry brief

    More than half of all deaths now result from largely preventable disease. In the future, Healthcare will be Health and Care, with a much stronger focus on keeping people healthy. In order to thrive in a market that demands Healthy Living innovation, business must first understand where the market

  • Health is wealth

    May 06, 2013 | Healthcare | Business Standard

    India's healthcare system is giving rise to a unique opportunity that rewards early diagnostic and healthcare interventions. This will guarantee a better return on investment for a sustainable future.